 | • レポートコード：GIR-107A14575 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ジェネリック医薬品有効成分のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ジェネリック医薬品有効成分の種類別市場規模（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）、用途別市場規模（腫瘍、糖尿病、心血管疾患、CNS＆神経障害、内分泌学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ジェネリック医薬品有効成分の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer, Inc. (U.S.)、Novartis International AG (Switzerland)、Sanofi (France)、Boehringer Ingelheim (Germany)、Bristol-Myers Squibb (U.S.)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (U.S.)、GlaxoSmithKline plc (U.K.)、Merck & Co., Inc. (U.S.)、AbbVie Inc. (U.S.) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子 ・用途別分析2016年-2026年：腫瘍、糖尿病、心血管疾患、CNS＆神経障害、内分泌学、その他 ・ジェネリック医薬品有効成分の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ジェネリック医薬品有効成分のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ジェネリック医薬品有効成分のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ジェネリック医薬品有効成分の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ジェネリック医薬品有効成分の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Generic Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Generic Active Pharmaceutical Ingredients size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Generic Active Pharmaceutical Ingredients market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Generic Active Pharmaceutical Ingredients market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors
Market segment by Application can be divided into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others
The key market players for global Generic Active Pharmaceutical Ingredients market are listed below:
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Generic Active Pharmaceutical Ingredients product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Active Pharmaceutical Ingredients, with price, sales, revenue and global market share of Generic Active Pharmaceutical Ingredients from 2019 to 2021.
Chapter 3, the Generic Active Pharmaceutical Ingredients competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Active Pharmaceutical Ingredients breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Generic Active Pharmaceutical Ingredients market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Generic Active Pharmaceutical Ingredients sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Generic Active Pharmaceutical Ingredients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Active Pharmaceutical Ingredients Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies
1.2.3 Hormones
1.2.4 Cytokines
1.2.5 Fusion Proteins
1.2.6 Therapeutic Enzymes
1.2.7 Vaccines
1.2.8 Blood Factors
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Active Pharmaceutical Ingredients Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Others
1.4 Global Generic Active Pharmaceutical Ingredients Market Size & Forecast
1.4.1 Global Generic Active Pharmaceutical Ingredients Sales in Value (2016-2026))
1.4.2 Global Generic Active Pharmaceutical Ingredients Sales in Volume (2016-2026)
1.4.3 Global Generic Active Pharmaceutical Ingredients Price by Type (2016-2026) & (USD/MT)
1.5 Global Generic Active Pharmaceutical Ingredients Production Capacity Analysis
1.5.1 Global Generic Active Pharmaceutical Ingredients Total Production Capacity (2016-2026)
1.5.2 Global Generic Active Pharmaceutical Ingredients Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Active Pharmaceutical Ingredients Market Drivers
1.6.2 Generic Active Pharmaceutical Ingredients Market Restraints
1.6.3 Generic Active Pharmaceutical Ingredients Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer, Inc. (U.S.)
2.1.1 Pfizer, Inc. (U.S.) Details
2.1.2 Pfizer, Inc. (U.S.) Major Business
2.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
2.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis International AG (Switzerland)
2.2.1 Novartis International AG (Switzerland) Details
2.2.2 Novartis International AG (Switzerland) Major Business
2.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product and Services
2.2.4 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi (France)
2.3.1 Sanofi (France) Details
2.3.2 Sanofi (France) Major Business
2.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Product and Services
2.3.4 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Boehringer Ingelheim (Germany)
2.4.1 Boehringer Ingelheim (Germany) Details
2.4.2 Boehringer Ingelheim (Germany) Major Business
2.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product and Services
2.4.4 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bristol-Myers Squibb (U.S.)
2.5.1 Bristol-Myers Squibb (U.S.) Details
2.5.2 Bristol-Myers Squibb (U.S.) Major Business
2.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
2.5.4 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Teva Pharmaceutical Industries Ltd. (Israel)
2.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Details
2.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Eli Lilly and Company (U.S.)
2.7.1 Eli Lilly and Company (U.S.) Details
2.7.2 Eli Lilly and Company (U.S.) Major Business
2.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
2.7.4 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GlaxoSmithKline plc (U.K.)
2.8.1 GlaxoSmithKline plc (U.K.) Details
2.8.2 GlaxoSmithKline plc (U.K.) Major Business
2.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product and Services
2.8.4 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Merck & Co., Inc. (U.S.)
2.9.1 Merck & Co., Inc. (U.S.) Details
2.9.2 Merck & Co., Inc. (U.S.) Major Business
2.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
2.9.4 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 AbbVie Inc. (U.S.)
2.10.1 AbbVie Inc. (U.S.) Details
2.10.2 AbbVie Inc. (U.S.) Major Business
2.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
2.10.4 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Generic Active Pharmaceutical Ingredients Sales by Manufacturer
3.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Generic Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Generic Active Pharmaceutical Ingredients
3.4 Market Concentration Rate
3.4.1 Top 3 Generic Active Pharmaceutical Ingredients Manufacturer Market Share
3.4.2 Top 6 Generic Active Pharmaceutical Ingredients Manufacturer Market Share
3.5 Global Generic Active Pharmaceutical Ingredients Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Generic Active Pharmaceutical Ingredients Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Generic Active Pharmaceutical Ingredients Market Size by Region
4.1.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
4.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
4.2 North America Generic Active Pharmaceutical Ingredients Revenue (2016-2026)
4.3 Europe Generic Active Pharmaceutical Ingredients Revenue (2016-2026)
4.4 Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue (2016-2026)
4.5 South America Generic Active Pharmaceutical Ingredients Revenue (2016-2026)
4.6 Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Type (2016-2026)
5.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type (2016-2026)
5.3 Global Generic Active Pharmaceutical Ingredients Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Application (2016-2026)
6.2 Global Generic Active Pharmaceutical Ingredients Revenue by Application (2016-2026)
6.3 Global Generic Active Pharmaceutical Ingredients Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Generic Active Pharmaceutical Ingredients Sales by Type (2016-2026)
7.2 North America Generic Active Pharmaceutical Ingredients Sales by Application (2016-2026)
7.3 North America Generic Active Pharmaceutical Ingredients Market Size by Country
7.3.1 North America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
7.3.2 North America Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Generic Active Pharmaceutical Ingredients Sales by Type (2016-2026)
8.2 Europe Generic Active Pharmaceutical Ingredients Sales by Application (2016-2026)
8.3 Europe Generic Active Pharmaceutical Ingredients Market Size by Country
8.3.1 Europe Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
8.3.2 Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Type (2016-2026)
9.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2016-2026)
9.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Market Size by Region
9.3.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Generic Active Pharmaceutical Ingredients Sales by Type (2016-2026)
10.2 South America Generic Active Pharmaceutical Ingredients Sales by Application (2016-2026)
10.3 South America Generic Active Pharmaceutical Ingredients Market Size by Country
10.3.1 South America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
10.3.2 South America Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Type (2016-2026)
11.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Application (2016-2026)
11.3 Middle East & Africa Generic Active Pharmaceutical Ingredients Market Size by Country
11.3.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Generic Active Pharmaceutical Ingredients Typical Distributors
12.3 Generic Active Pharmaceutical Ingredients Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Generic Active Pharmaceutical Ingredients Revenue by Type, (USD Million), 2021-2026
Table 2. Global Generic Active Pharmaceutical Ingredients Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer, Inc. (U.S.) Major Business
Table 5. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 6. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis International AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Novartis International AG (Switzerland) Major Business
Table 9. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product and Services
Table 10. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi (France) Major Business
Table 13. Sanofi (France) Generic Active Pharmaceutical Ingredients Product and Services
Table 14. Sanofi (France) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim (Germany) Major Business
Table 17. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product and Services
Table 18. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bristol-Myers Squibb (U.S.) Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb (U.S.) Major Business
Table 21. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 22. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. (Israel) Major Business
Table 25. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly and Company (U.S.) Major Business
Table 29. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 30. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline plc (U.K.) Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline plc (U.K.) Major Business
Table 33. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product and Services
Table 34. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Merck & Co., Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 36. Merck & Co., Inc. (U.S.) Major Business
Table 37. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 38. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AbbVie Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 40. AbbVie Inc. (U.S.) Major Business
Table 41. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 42. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Generic Active Pharmaceutical Ingredients Sales by Manufacturer (2019-2021e) & (K MT)
Table 44. Global Generic Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Generic Active Pharmaceutical Ingredients, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Generic Active Pharmaceutical Ingredients Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Generic Active Pharmaceutical Ingredients Production Site of Key Manufacturer
Table 48. Generic Active Pharmaceutical Ingredients New Entrant and Capacity Expansion Plans
Table 49. Generic Active Pharmaceutical Ingredients Mergers & Acquisitions in the Past Five Years
Table 50. Global Generic Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (K MT)
Table 51. Global Generic Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (K MT)
Table 52. Global Generic Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Generic Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 55. Global Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 56. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Generic Active Pharmaceutical Ingredients Price by Type (2016-2021e) & (USD/MT)
Table 59. Global Generic Active Pharmaceutical Ingredients Price by Type (2021-2026) & (USD/MT)
Table 60. Global Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 61. Global Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 62. Global Generic Active Pharmaceutical Ingredients Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Generic Active Pharmaceutical Ingredients Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Generic Active Pharmaceutical Ingredients Price by Application (2016-2021e) & (USD/MT)
Table 65. Global Generic Active Pharmaceutical Ingredients Price by Application (2021-2026) & (USD/MT)
Table 66. North America Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 67. North America Generic Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 68. North America Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Generic Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 71. North America Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 72. North America Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 73. North America Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 74. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 75. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 76. Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 79. Europe Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 80. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 81. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 82. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (K MT)
Table 83. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (K MT)
Table 84. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 87. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 88. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 89. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 90. South America Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 91. South America Generic Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 92. South America Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Generic Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 95. South America Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 96. South America Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 97. South America Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 98. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 99. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 100. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 103. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 104. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 105. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Generic Active Pharmaceutical Ingredients Typical Distributors
Table 109. Generic Active Pharmaceutical Ingredients Typical Customers
List of Figures
Figure 1. Generic Active Pharmaceutical Ingredients Picture
Figure 2. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Hormones
Figure 5. Cytokines
Figure 6. Fusion Proteins
Figure 7. Therapeutic Enzymes
Figure 8. Vaccines
Figure 9. Blood Factors
Figure 10. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 11. Oncology
Figure 12. Diabetes
Figure 13. Cardiovascular Disease
Figure 14. CNS and Neurological Disorders
Figure 15. Endocrinology
Figure 16. Others
Figure 17. Global Generic Active Pharmaceutical Ingredients Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 18. Global Generic Active Pharmaceutical Ingredients Market Size and Forecast (2016-2026) & (USD Million)
Figure 19. Global Generic Active Pharmaceutical Ingredients Sales (2016-2026) & (K MT)
Figure 20. Global Generic Active Pharmaceutical Ingredients Price by Type (2016-2026) & (USD/MT)
Figure 21. Global Generic Active Pharmaceutical Ingredients Production Capacity (2016-2026) & (K MT)
Figure 22. Global Generic Active Pharmaceutical Ingredients Production Capacity by Geographic Region: 2020 VS 2021
Figure 23. Generic Active Pharmaceutical Ingredients Market Drivers
Figure 24. Generic Active Pharmaceutical Ingredients Market Restraints
Figure 25. Generic Active Pharmaceutical Ingredients Market Trends
Figure 26. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Manufacturer in 2020
Figure 27. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Manufacturer in 2020
Figure 28. Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. Top 3 Generic Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 30. Top 6 Generic Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 31. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 32. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 33. North America Generic Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 34. Europe Generic Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 35. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 36. South America Generic Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 37. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 38. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 39. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2026)
Figure 40. Global Generic Active Pharmaceutical Ingredients Price by Type (2016-2026) & (USD/MT)
Figure 41. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 42. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2026)
Figure 43. Global Generic Active Pharmaceutical Ingredients Price by Application (2016-2026) & (USD/MT)
Figure 44. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 45. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 46. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 47. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 48. United States Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 52. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 53. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 54. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 55. Germany Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 64. China Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Korea Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 71. South America Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 72. South America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 73. South America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 78. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Egypt Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. South Africa Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界の腫瘍ジェネリック注射薬市場 2021：企業別、地域別、種類・用途別 The Oncology Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界の抗生物質有効成分（API）市場 2021：企業別、地域別、種類・用途別 The Antibiotics Active Pharmaceutical Ingredient (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 世界の特殊成分市場予測（～2024年） Scope of the Report: The worldwide market for Specialty Ingredients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Specialty Ingredi…
- 世界のアクティブパッケージング市場 2021：企業別、地域別、種類・用途別 The Active Packaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…